181 related articles for article (PubMed ID: 14586902)
1. Treatment of patients with hepatitis C virus on the waiting list.
Everson GT
Liver Transpl; 2003 Nov; 9(11):S90-4. PubMed ID: 14586902
[TBL] [Abstract][Full Text] [Related]
2. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
[TBL] [Abstract][Full Text] [Related]
3. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
[TBL] [Abstract][Full Text] [Related]
4. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience.
Burra P; Targhetta S; Pevere S; Boninsegna S; Guido M; Canova D; Brolese A; Masier A; D'Aloiso C; Germani G; Tomat S; Fagiuoli S
Transplant Proc; 2006 May; 38(4):1127-30. PubMed ID: 16757285
[TBL] [Abstract][Full Text] [Related]
5. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.
Giostra E; Kullak-Ublick GA; Keller W; Fried R; Vanlemmens C; Kraehenbuhl S; Locher S; Egger HP; Clavien PA; Hadengue A; Mentha G; Morel P; Negro F
Transpl Int; 2004 May; 17(4):169-76. PubMed ID: 15060764
[TBL] [Abstract][Full Text] [Related]
6. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
7. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
10. I favor therapy for hepatitis C virus recurrence after transplantation.
Samuel D
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S55-8. PubMed ID: 12362300
[No Abstract] [Full Text] [Related]
11. Hepatitis C therapy before and after liver transplantation.
Terrault NA
Liver Transpl; 2008 Oct; 14 Suppl 2():S58-66. PubMed ID: 18825697
[TBL] [Abstract][Full Text] [Related]
12. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-alpha plus ribavirin.
Legrand-Abravanel F; Sandres-Sauné K; Barange K; Alric L; Moreau J; Desmorat P; Vinel JP; Izopet J
J Infect Dis; 2004 Apr; 189(8):1397-400. PubMed ID: 15073676
[TBL] [Abstract][Full Text] [Related]
14. Management of recurrent hepatitis C after liver transplantation: a concise review.
Szabo G; Katz E; Bonkovsky HL
Am J Gastroenterol; 2000 Sep; 95(9):2164-70. PubMed ID: 11007212
[TBL] [Abstract][Full Text] [Related]
15. New approaches to treatment of recurrent hepatitis C virus following liver transplantation using ribavirin.
Bizollon T; Adahm M; Ducerf C; Baulieux J; Trepo C
Transplant Proc; 1996 Oct; 28(5):2842-3. PubMed ID: 8908092
[No Abstract] [Full Text] [Related]
16. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin.
Bizollon T; Ducerf C; Trépo C
J Hepatol; 1995; 23 Suppl 2():22-5. PubMed ID: 8720290
[TBL] [Abstract][Full Text] [Related]
17. [Hepatitis C virus genotype 4: epidemiology and treatment].
Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
[No Abstract] [Full Text] [Related]
18. Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.
Fontaine H; Chaix ML; Lagneau JL; Bréchot C; Pol S
Lancet; 2000 Jul; 356(9223):41. PubMed ID: 10892765
[TBL] [Abstract][Full Text] [Related]
19. [Clinical, virologic and pathologic features of asymptomatic hepatitis C virus carriers].
Shindo M; Okuno T
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):376-80. PubMed ID: 15359825
[No Abstract] [Full Text] [Related]
20. [Kidney transplantation in patients positive for hepatitis C virus].
Campistol JM; Esforzado N; Morales JM; Barrera JM
Nefrologia; 2002; 22 Suppl 5():62-6. PubMed ID: 12107920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
